John Saharek, president of ImprimisRX, speaks with 

's David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting, including:

 Moxi-Brom (moxifloxacin hydrochloride 0.5% and bromfenac sodium sesquihydrate 0.075%)

 Klarity-CL drops (cyclosporine 0.1% / loteprednol etabonate 0.2% ophthalmic suspension)

Tim-Brim-Dor-Bim (prednisolone acetate 1%, gatifloxacin 0.5%, bromfenac 0.075%).

The American Academy of Ophthalmology (AAO) annual meeting was held November 12 to 15 at the Ernest N. Morial Convention Centre in New Orleans, Louisiana, United States. The event included Subspecialty Days and a virtual component for remote participation.

Video Series

Expert Interviews

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times Europe® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community

Conference

ImprimisRx President John Saharek shares an update on a few of the company's latest products during AAO 2021. 

President John Saharek on the ImprimisRx pipeline, details 3 products